|
|
 |
|
REGN: Regeneron Pharmaceutical Inc - Stock News |
Enter Ticker:
|
|
| Nov 20, 2009 |
AnaptysBio Taps Dr. Sean Stevens as Director of Cell Biology |
| Nov 17, 2009 |
Stock research report available on Regeneron Pharmaceuticals (NASDAQ:REGN) from SmarTrend Analytics |
| Nov 11, 2009 |
Sanofi-Aventis, Regeneron Expand Partnership |
| Nov 11, 2009 |
REGN: Conference call regarding to discuss the company's expanded strategic antibody collaboration with sanofi-aventis @ 08:30 ET Today [delayed] |
| Nov 10, 2009 |
Stock research report available on Regeneron Pharmaceuticals (NASDAQ:REGN) from SmarTrend Analytics |
| Nov 10, 2009 |
Regeneron Announces Conference Call to Discuss Expanded Antibody Collaboration with Sanofi-aventis |
| Nov 10, 2009 |
Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration |
| Nov 10, 2009 |
Lower Q3 Loss for Regeneron |
| Nov 04, 2009 |
Regeneron Pharmaceuticals Down 25.9% Since SmarTrend's Sell Recommendation |
| Nov 04, 2009 |
BUYINS.NET: Regeneron Pharmaceuticals (REGN) Down After BUYINS.NET Report Predicted Weakness After Earnings |
| Nov 03, 2009 |
Regeneron Reports Third Quarter 2009 Financial and Operating Results |
| Nov 02, 2009 |
BUYINS.NET: REGN, EGLE, VG, SSS, DSCO, SRDX Expected To Be Lower After Earnings Releases on Wednesday |
| Oct 30, 2009 |
BUYINS.NET: CTL, REGN, ROCK, LZB, ALX, WSC Expected To Be Higher Leading Up To Next Earnings Releases |
| Oct 29, 2009 |
CORRECTION: Analyst Downgrades for October 29th |
| Oct 28, 2009 |
Regeneron Pharmaceuticals Down 18.3% Since SmarTrend's Sell Recommendation |
| |
| ZACKS COMMENTARY FOR REGN |
|
|
|
Sponsored Links 
-0.21